ACTIVE

IMPROVE2CARE

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
107,3 k €
+2492.6% YoY
Gross margin
167,7 k €
+993.3% YoY
Equity
66,1 k €
+12.4% YoY

What does IMPROVE2CARE do?

IMPROVE2CARE is a Private limited company incorporated in 2014. Its main activity is: Specialist medical practice activities. Its registered office is in Keerbergen.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0546.651.517
Incorporation
18/02/2014
Legal form
Private limited company
Registered office
Bosduifweg 30
3140 Keerbergen · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Activities (NACE)
86220Specialist medical practice activities· main86220Specialist medical practice activities82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.85599Other education n.e.c.85599Other education n.e.c.
Contacts
2 public details availableLog in to view
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 9 financial years

202420232022202120182017201620152014
Income statement
Gross margin167,7 k €15,3 k €56,3 k €56,1 k €35,3 k €42 k €52,8 k €30,1 k €60,7 k €
EBITDA165,6 k €14,4 k €53,8 k €55,1 k €34,3 k €41,1 k €51,5 k €28,8 k €57,7 k €
Operating result152,8 k €323,6 €41,8 k €39,3 k €23,5 k €30,8 k €45,1 k €23,6 k €55,4 k €
Net result107,3 k €-4,5 k €27 k €22,4 k €15,2 k €16,3 k €25,5 k €9,5 k €29,3 k €
Balance sheet
Equity66,1 k €58,8 k €79,6 k €89,4 k €93,1 k €93 k €76,6 k €51,1 k €41,7 k €
Total assets237,4 k €136,5 k €196,8 k €159,1 k €153,3 k €162,8 k €141,4 k €95,2 k €76,9 k €
Cash93,7 k €28,5 k €94,5 k €119,6 k €93,9 k €108,5 k €41,1 k €12,8 k €28,6 k €
Debts171,3 k €77,6 k €117,2 k €69,7 k €60,2 k €69,9 k €64,8 k €44 k €35,2 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 2 ended

Active mandates

Inge Wouters

Director · since 14 février 2014

Active

Ended mandates

INGE WOUTERS

Manager · since 14 février 2014

Ended
Inge Wouters

Manager

Ended
Annual accounts

Full financial information

202420232022202120202019
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/07/202531/07/202429/08/202331/08/202210/09/202125/03/2020
General meeting20/06/202521/06/202416/06/202330/06/202231/07/202123/03/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202420/06/202515/07/2025DutchPDF
Micro model31/12/202321/06/202431/07/2024DutchPDF
Micro model31/12/202216/06/202329/08/2023DutchPDF
Micro model31/12/202130/06/202231/08/2022DutchPDF
Micro model31/12/202031/07/202110/09/2021DutchPDF
Micro model31/12/201923/03/202025/03/2020DutchPDF
Micro model31/12/201828/06/201917/07/2019DutchPDF
Micro model31/12/201715/06/201809/07/2018DutchPDF
Micro model31/12/201631/08/201731/08/2017DutchPDF
Abridged model31/12/201517/06/201619/08/2016DutchPDF
Abridged model31/12/201419/06/201526/08/2015DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 2 ended

Active mandates

Inge Wouters

Director · since 14 février 2014

Active

Ended mandates

INGE WOUTERS

Manager · since 14 février 2014

Ended
Inge Wouters

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates18/01/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024107,3 k €↑
  2. 2023
    Annual accounts 2023-4,5 k €↓
  3. 2022
    Annual accounts 202227 k €↑
  4. 2021
    Annual accounts 202122,4 k €↑
  5. 2021
    Name changeImprove2Care
  6. 2018
    Annual accounts 201815,2 k €↓
  7. 2017
    Annual accounts 201716,3 k €↓
  8. 2016
    Annual accounts 201625,5 k €↑
  9. 2015
    Annual accounts 20159,5 k €↓
  10. 2014
    Annual accounts 201429,3 k €
  11. 18/02/2014
    IncorporationPrivate limited company
  12. 2014
    Name changeB.V.B.A. Dr. Inge Wouters, urologie